The factor Xa inhibitor edoxaban might reduce the risk of several adverse events—including stroke, major bleeding and all-cause death—when compared to warfarin, according to a real-world study of Korean patients with atrial fibrillation (AFib).
Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.
A screening program for top teen soccer players in England identified heart disorders associated with sudden cardiac death in one out of every 266 individuals. But among the eight athletes who eventually died of sudden cardiac arrest, six of them had normal electrocardiographic and echocardiographic findings.
Medtronic has launched the pilot study of its extravascular implantable cardioverter defibrillator (EV ICD), which is designed to deliver defibrillation and antitachycardia pacing without transvenous leads.
The U.S. Preventive Task Force (USPSTF) issued a Grade I recommendation, indicating there is insufficient evidence assessing the benefits and harms of screening for atrial fibrillation (AFib) with electrocardiography (ECG) in patients 65 and older with previously undiagnosed AFib.
Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study in JAMA Network Open suggests clinical outcomes are worse for patients with AFib, even if they have the same values on the standard CHA2DS2-VASc scoring system.
A New Jersey cardiologist specializing in electrophysiology was sentenced July 31 to 20 months in prison for billing the Veterans Affairs (VA) program hundreds of thousands of dollars for services he never performed.
Patients without electrocardiographic (ECG) evidence of left ventricular hypertrophy were significantly more likely to die in the two years after transcatheter aortic valve replacement (TAVR), researchers reported July 30 in Clinical Cardiology.
A new North American consensus statement published July 30 in Circulation recommends a non-vitamin K antagonist oral anticoagulant (NOAC) and the P2Y12 inhibitor clopidogrel for most patients with atrial fibrillation undergoing PCI.
A calcium-channel blocker delivered as a nasal spray rapidly restored individuals with paroxysmal supraventricular tachycardia (SVT) to normal sinus rhythm in a phase 2 study, raising the possibility that the drug could be self-administered in a real-world setting and prevent trips to the emergency department.
Epinephrine doses administered by paramedics significantly improved the odds of 30-day survival for patients following out-of-hospital cardiac arrest (OHCA), according to a randomized, placebo-controlled trial published in the New England Journal of Medicine. The survivors who received epinephrine, however, had worse neurological outcomes.
Asthma and uncontrolled asthma are associated with a 38 percent increased risk of developing atrial fibrillation (AFib), according to new research published in JAMA Cardiology.
Improving the use of ICDs will involve discerning appropriate from inappropriate shocks, standardizing post-shock protocols and refining device programming.
Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.
The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of Preventive Cardiology.
Blacks who survive in-hospital cardiac arrest (IHCA) are 28 percent less likely to live to one year after discharge and 33 percent less likely to survive five years when compared to white counterparts, suggesting a disparity in follow-up care.
Electrophysiology & Arrhythmia, Practice Management
Individuals at high risk for atrial fibrillation (AFib) who utilized a home-based wearable electrocardiogram (ECG) patch had a higher rate of AFib diagnosis after four months compared to delayed monitoring.
Electrophysiology & Arrhythmia
Nonsteroidal anti-inflammatory drugs (NSAIDs) can be dangerous for patients with atrial fibrillation (AFib) when taken on top of oral anticoagulants, suggests a post hoc analysis of the RE-LY trial published in the Journal of the American College of Cardiology.
Vascular & Endovascular, Electrophysiology & Arrhythmia
Boston Scientific plans to acquire Cryterion Medical, a company developing a single-shot cryoablation platform to treat patients with atrial fibrillation (AFib). Already an investor in the company, Boston Scientific will purchase the remaining 65 percent stake for $202 million in up-front cash.
Electrophysiology & Arrhythmia, Healthcare Economics & Policy
A federal investigation into the potential overuse of primary prevention implantable cardioverter defibrillators (ICDs) appears to have made hospitals more judicious in their use of the devices, according to a study published July 3 in the Journal of the American Medical Association.
Electrophysiology & Arrhythmia, Healthcare Economics & Policy, Practice Management
Jul 03, 2018 | Imaging
Two neurologists from Stanford University believe their specialty must take the lead on ensuring patients with cardiovascular implantable electronic devices (CIEDs) have access to MRI when necessary.
Imaging, Electrophysiology & Arrhythmia